Health inspection·July 17, 2024

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to administer medications within one (1) hour of the due scheduled time (either one hour before or one hour after) for one of three sampled residents (Resident 1). This deficient practice had the potential to result in ineffective management of Resident 1 ' s neuropathy (weakness, numbness, and pain from nerve damage, usually in the hands and feet) and anxiety (intense, excessive, and persistent worry and fear about everyday situations). Findings: A review of Resident 1 ' s admission record indicated that Resident 1 was admitted to the facility on [DATE] with diagnoses that include osteoarthritis (a degenerative joint disease, in which the tissues in the joint break down over time), major depressive disorder (a mental health condition that causes a persistently low or depressed mood and a loss of interest in activities that once brought joy), anxiety and type 2 diabetes (a condition that happens because of a problem in the way the body regulates and uses sugar as a fuel). A review of Resident 1 ' s History and Physical dated 3/1/2024, indicated Resident 1 had the capacity to make needs known and decisions. A review of Resident 1 ' s Minimum Data Set (MDS - a comprehensive assessment and screening tool) dated 7/1/2024, indicated Resident 1 had moderate cognitive impairment (problems with a person's ability to think, learn, remember, use judgement, and make decisions). The MDS further indicated that Resident 1 is dependent on facility staff with activities of daily living (ADL- are activities related to personal care, they include bathing or showering, dressing, getting in and out of bed or a chair, walking, and using the toilet). A review of Resident 1 ' s Physician Order indicated the following orders: 1. Gabapentin (medication used to treat neuropathy) Oral Tablet 600 milligrams (mg-unit of measurement), give two (2) tablets three times a day for neuropathy dated 1/11/2023. 2. Buspirone (medication used to anxiety) Oral Tablet 10 mg, give one (1) tablet by three times a day dated 1/11/2023. A review of Resident 1 ' s Medication Administration Record (MAR- a report detailing the medications administered to a resident by a healthcare professional) for 7/2/2024 indicated the following: (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 056337 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 056337 B. Wing A. Building (X3) DATE SURVEY COMPLETED 07/17/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Panorama Gardens Nursing and Rehabilitation Center 9541 Van Nuys Blvd. Panorama City, CA 91402 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)